ATRA PEER ANALYSIS

Atara Biotherapeutics Inc — metric-by-metric comparison with peers and the industry median

ATRAAtara Biotherapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

ATRAIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	ATRA	RTALB	MSB	TLX	Ind. Median
P/E	—	4.89	—	—	17.91
P/B	-4.40●	0.61	—	6.37	3.51
EV/EBITDA	—	74.61●	—	120.14	14.82
P/S	7.09	6.67	31.61	3.24●	10.89

Financial Health
Metric	ATRA	RTALB	MSB	TLX	Ind. Median
Current Ratio	2.16●	1.21	—	1.43	5.90
Debt/Equity	-27.0%●	1.2%	—	112.3%	10.9%
NetDebt/EBITDA	-0.32●	0.90	—	13.13	1.15

Profitability
Metric	ATRA	RTALB	MSB	TLX	Ind. Median
Net Margin	-40.9%	136.3%●	-115.3%	-0.9%	-125.7%
ROE	—	15.1%●	-11.3%	-1.8%	-47.5%
ROA	-23.1%	13.1%●	-8.6%	-0.7%	-35.8%
EBITDA Margin	-23.7%	9.0%●	-76.6%	3.0%	-105.8%

Growth + Dividend
Metric	ATRA	RTALB	MSB	TLX	Ind. Median
Rev. Growth	-88.4%	24.0%	410.4%●	56.3%	5.1%
NI Growth	—	134.0%	—	—	12.1%
Div. Yield	—	0.0%●	0.0%●	—	0.2%
Payout	—	0.0%	0.0%	—	0.0%

Valuation
Metric	ATRA	OBIO	CRBU	HUMA	PLX	ALDX	Ind. Median
P/E	—	—	—	—	12.57	—	17.91
P/B	-4.40●	3.16	1.71	12.08	2.87	3.25	3.51
EV/EBITDA	—	—	—	—	6.69	—	14.82
P/S	7.09	4.92	15.57	69.68	2.52●	—	10.89

Financial Health
Metric	ATRA	OBIO	CRBU	HUMA	PLX	ALDX	Ind. Median
Current Ratio	2.16	7.03●	6.22	3.93	3.15	2.72	5.90
Debt/Equity	-27.0%●	66.0%	26.4%	566.9%	12.6%	36.8%	10.9%
NetDebt/EBITDA	-0.32	1.15	0.81	-0.22	-1.94●	1.96	1.15

Profitability
Metric	ATRA	OBIO	CRBU	HUMA	PLX	ALDX	Ind. Median
Net Margin	-40.9%	-167.0%	-1,189.1%	-4,840.8%	20.1%●	—	-125.7%
ROE	—	-161.1%	-83.5%	-409.5%	27.3%●	-51.8%	-47.5%
ROA	-23.1%	-68.4%	-63.0%	-71.5%	17.4%●	-34.3%	-35.8%
EBITDA Margin	-23.7%	-161.1%	-999.5%	-3,956.7%	29.2%●	—	-105.8%

Growth + Dividend
Metric	ATRA	OBIO	CRBU	HUMA	PLX	ALDX	Ind. Median
Rev. Growth	-88.4%	1,033.9%●	13.0%	-74.0%	27.8%	-100.0%	5.1%
NI Growth	—	—	—	—	292.3%	—	12.1%
Div. Yield	—	—	—	0.0%	—	—	0.2%
Payout	—	—	—	0.0%	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on ATRA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.